supriya
The pharma co reported a 57% rise in Q1 profit, rev from ops up 22% Y/Y
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.